Correlation Between BioCryst Pharmaceuticals and CTi Biopharma

Specify exactly 2 symbols:
Can any of the company-specific risk be diversified away by investing in both BioCryst Pharmaceuticals and CTi Biopharma at the same time? Although using a correlation coefficient on its own may not help to predict future stock returns, this module helps to understand the diversifiable risk of combining BioCryst Pharmaceuticals and CTi Biopharma into the same portfolio, which is an essential part of the fundamental portfolio management process.
By analyzing existing cross correlation between BioCryst Pharmaceuticals and CTi Biopharma Corp, you can compare the effects of market volatilities on BioCryst Pharmaceuticals and CTi Biopharma and check how they will diversify away market risk if combined in the same portfolio for a given time horizon. You can also utilize pair trading strategies of matching a long position in BioCryst Pharmaceuticals with a short position of CTi Biopharma. Check out your portfolio center. Please also check ongoing floating volatility patterns of BioCryst Pharmaceuticals and CTi Biopharma.

Diversification Opportunities for BioCryst Pharmaceuticals and CTi Biopharma

0.0
  Correlation Coefficient

Pay attention - limited upside

The 3 months correlation between BioCryst and CTi is 0.0. Overlapping area represents the amount of risk that can be diversified away by holding BioCryst Pharmaceuticals and CTi Biopharma Corp in the same portfolio, assuming nothing else is changed. The correlation between historical prices or returns on CTi Biopharma Corp and BioCryst Pharmaceuticals is a relative statistical measure of the degree to which these equity instruments tend to move together. The correlation coefficient measures the extent to which returns on BioCryst Pharmaceuticals are associated (or correlated) with CTi Biopharma. Values of the correlation coefficient range from -1 to +1, where. The correlation of zero (0) is possible when the price movement of CTi Biopharma Corp has no effect on the direction of BioCryst Pharmaceuticals i.e., BioCryst Pharmaceuticals and CTi Biopharma go up and down completely randomly.

Pair Corralation between BioCryst Pharmaceuticals and CTi Biopharma

If you would invest  706.00  in BioCryst Pharmaceuticals on September 17, 2024 and sell it today you would earn a total of  47.00  from holding BioCryst Pharmaceuticals or generate 6.66% return on investment over 90 days.
Time Period3 Months [change]
DirectionFlat 
StrengthInsignificant
Accuracy5.0%
ValuesDaily Returns

BioCryst Pharmaceuticals  vs.  CTi Biopharma Corp

 Performance 
       Timeline  
BioCryst Pharmaceuticals 

Risk-Adjusted Performance

0 of 100

 
Weak
 
Strong
Very Weak
Over the last 90 days BioCryst Pharmaceuticals has generated negative risk-adjusted returns adding no value to investors with long positions. In spite of fairly strong basic indicators, BioCryst Pharmaceuticals is not utilizing all of its potentials. The current stock price disturbance, may contribute to short-term losses for the investors.
CTi Biopharma Corp 

Risk-Adjusted Performance

0 of 100

 
Weak
 
Strong
Very Weak
Over the last 90 days CTi Biopharma Corp has generated negative risk-adjusted returns adding no value to investors with long positions. In spite of rather sound forward indicators, CTi Biopharma is not utilizing all of its potentials. The current stock price tumult, may contribute to shorter-term losses for the shareholders.

BioCryst Pharmaceuticals and CTi Biopharma Volatility Contrast

   Predicted Return Density   
       Returns  

Pair Trading with BioCryst Pharmaceuticals and CTi Biopharma

The main advantage of trading using opposite BioCryst Pharmaceuticals and CTi Biopharma positions is that it hedges away some unsystematic risk. Because of two separate transactions, even if BioCryst Pharmaceuticals position performs unexpectedly, CTi Biopharma can make up some of the losses. Pair trading also minimizes risk from directional movements in the market. For example, if an entire industry or sector drops because of unexpected headlines, the short position in CTi Biopharma will offset losses from the drop in CTi Biopharma's long position.
The idea behind BioCryst Pharmaceuticals and CTi Biopharma Corp pairs trading is to make the combined position market-neutral, meaning the overall market's direction will not affect its win or loss (or potential downside or upside). This can be achieved by designing a pairs trade with two highly correlated stocks or equities that operate in a similar space or sector, making it possible to obtain profits through simple and relatively low-risk investment.
Check out your portfolio center.
Note that this page's information should be used as a complementary analysis to find the right mix of equity instruments to add to your existing portfolios or create a brand new portfolio. You can also try the Funds Screener module to find actively-traded funds from around the world traded on over 30 global exchanges.

Other Complementary Tools

Portfolio Dashboard
Portfolio dashboard that provides centralized access to all your investments
Volatility Analysis
Get historical volatility and risk analysis based on latest market data
CEOs Directory
Screen CEOs from public companies around the world
Pattern Recognition
Use different Pattern Recognition models to time the market across multiple global exchanges
Portfolio Rebalancing
Analyze risk-adjusted returns against different time horizons to find asset-allocation targets